Association between non-medical and prescriptive usage of opioids

Drug and Alcohol Dependence

Volumn 82, Issue 2, 2006, Pages 135-142

  Dasgupta, Nabarun ^a   Kramer, E Douglas ^a   Zalman, Mary Ann ^a   Carino Jr , Salvatore ^a   Smith, Meredith Y ^a   Haddox, J David ^a   Wright IV, Curtis ^a  

^a PURDUE PHARMA L P   (United States)

Author keywords

Abuse; Abuse liability; Opioids; Pain; Post marketing surveillance; Prescription medications

Indexed keywords

ANALGESIC AGENT; CODEINE; DEXTROPROPOXYPHENE; FENTANYL; HYDROCODONE; HYDROMORPHONE; METHADONE; MORPHINE; OPIATE; OXYCODONE; PENTAZOCINE; PETHIDINE;

ARTICLE; DRUG ABUSE; DRUG POTENCY; DRUG USE; MORBIDITY; PRESCRIPTION; PRIORITY JOURNAL;

ANALGESICS; HUMANS; NARCOTICS; PRESCRIPTIONS, DRUG; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 33645227980     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2005.08.019     Document Type: Article

References (20)

1. American Academy of Pain Medicine and American Pain Society, 1997. The use of opioids for the treatment of chronic pain: a consensus statement from the American Academy of Pain Medicine and the American Pain Society. http://www.painmed.org/productpub/statements/pdfs/opioids.pdf (accessed June 20, 2005).
2. J.P. Caulkins What is the average price of an illicit drug? Addiction 89 1994 815 819
3. ® (tramadol hydrochloride) abuse in the United States Drug Alcohol Depend. 57 1999 7 22
4. J.A. Costa e Silva Evidence-based analysis of the worldwide abuse of licit and illicit drugs Hum. Psychopharmacol. 17 2002 131 140
5. Federation of State Medical Boards of the United States, 1998. Model guidelines for the use of controlled substances for the treatment of pain: a policy document of the Federation of States Medical Boards of the United States Inc. Dallas. http://www.fsmb.org/PolicyDocumentsandWhitePapers/ model_pain_guidelines.htm (accessed June 20, 2005).
6. K.M. Foley The treatment of cancer pain N. Engl. J. Med. 313 1985 84 95
7. A.M. Gilson, K.M. Ryan, D.E. Joranson, and J.L. Dahl A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002 J. Pain Symptom Manag. 28 2004 176 188
8. H.B. Gutstein, and H. Akil Opioid analgesics J.G. Hardman L.E. Limbird Goodman & Gilman's The Pharmacological Basis of Therapeutics 10th ed. 2001 McGraw-Hill New York 569 619
9. D.E. Joranson, K.M. Ryan, A.M. Gilson, and J.L. Dahl Trends in medical use and abuse of opioid analgesics J. Am. Med. Assoc. 283 2000 1710 1714
10. S. Novak, W.C. Nemeth, and K.A. Lawson Trends in medical use and abuse of sustained-release opioid analgesics: a revisit Pain Med. 5 2004 59 65
11. Single Convention on Narcotic Drugs, 1961 as amended by the 1972 Protocol Amending the Single Convention on Narcotic Drugs, 1961. United Nations. Available from http://www.incb.org/e/ind_conv.htm (accessed February 9, 2005).
12. Substance Abuse and Mental Health Services Administration (SAMHSA), 2002a. Office of Applied Studies, Results from the 2001 National Household Survey on Drug Abuse: Volume II. Technical Appendices and Selected Data Tables. NHSDA series H-18, DHHS publication No. (SMA) 02-3759. Rockville, MD.
13. Substance Abuse and Mental Health Services Administration (SAMHSA), 2002b. Office of Applied Studies, Emergency Department Trends from the Drug Abuse Warning Network, Final Estimates 1994-2001. DAWN Series D-21, DHHS Publication No. (SMA) 02-3635, Rockville, MD.
14. Substance Abuse and Mental Health Services Administration (SAMHSA), 2002c. Office of Applied Studies, Methodology. Series M-4, DHHS Publication No. (SMA) 02-3754, Rockville, MD. http://dawninfo.samhsa.gov/files/report.pdf (accessed January 27, 2005).
15. Substance Abuse and Mental Health Services Administration (SAMHSA), 2003a. Office of Applied Studies, Emergency Department Trends from the Drug Abuse Warning Network, Final Estimates 1995-2002. DAWN Series D-24, DHHS Publication No. (SMA) 03-3780, Rockville, MD.
16. Substance Abuse and Mental Health Services Administration (SAMHSA), 2003b. Office of Applied Studies, Overview of Findings from the 2003 National Survey on Drug Use and Health National Findings. Office of Applied Studies, NSDUH Series H-24, DHHS Publication No. (SMA) 04-3963, Rockville, MD. http://oas.samhsa.gov/nhsda.htm-HSDAinfo (accessed January 27, 2005).
17. Substance Abuse and Mental Health Services Administration (SAMHSA), 2004. Office of Applied Studies, Results from the 2003 National Household Survey on Drug Abuse: National Findings Office of Applied Studies, NSDUH Series H-25, DHHS Publication No. (SMA) 04-3964, Rockville, MD.
18. United Nations, 2004. Narcotic Drugs, Estimated World Requirements for 2004 - Statistics for 2002. New York 2004.
19. U.S. Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), 2005. March 2005. Guidance for Industry Development and Use of Risk Minimization Action Plans. http://www.fda.gov/cder/guidance/6358fnl.htm-_Toc67721189 (accessed June 29, 2005).
20. J. Zacny, G. Bigelow, P. Compton, K. Foley, M. Iguchi, and C. Sannerud College on Problems of drug dependence taskforce on prescriptions opioid non-medical use and abuse: position statement Drug Alcohol Depend. 69 2003 215 232